Your browser doesn't support javascript.
loading
Normal range of complement components during pregnancy: A prospective study.
He, Ying-Dong; Xu, Bing-Ning; Song, Di; Wang, Ya-Qin; Yu, Feng; Chen, Qian; Zhao, Ming-Hui.
Afiliação
  • He YD; Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
  • Xu BN; Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
  • Song D; Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
  • Wang YQ; Department of Medicine, Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
  • Yu F; Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
  • Chen Q; Department of Medicine, Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
  • Zhao MH; Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
Am J Reprod Immunol ; 83(2): e13202, 2020 02.
Article em En | MEDLINE | ID: mdl-31646704
ABSTRACT

PROBLEM:

The complement system plays a key role in normal placentation, and delicate regulation of complement system activation is critical for successful pregnancy. Therefore, establishing a normal range of complement components during pregnancy is important for clinical evaluation and research.

METHODS:

We performed a prospective study to investigate the normal range of complement components in circulation during different stages of pregnancy. Plasma concentrations of complement factor B (CFB), C1q, complement factor H (CFH), C3, C3c, and C4 were measured using an immunoturbidimetric assay; mannan-binding lectin (MBL), C3a, C5a, and soluble C5b-9 (sC5b-9) levels at different time points of pregnancy were determined by enzyme-linked immunosorbent assay (ELISA).

RESULTS:

A total of 733 plasma samples were collected from 362 women with a normal pregnancy and 65 samples from non-pregnant women. In the first trimester of pregnancy, the levels of CFB, CFH, MBL, C3c, C4, and C3a were 414.5 ± 85.9 mg/L (95% CI for mean 402.4-426.6 mg/L), 381.0 ± 89.0 mg/L (95% CI for mean 368.5-393.6 mg/L), 4274.5 ± 2752 ng/mL (95% CI for mean 3881.1-4656.4 ng/mL), 1346.9 ± 419.8 mg/L (95% CI for mean 1287.7-1406.0 mg/L), 357.4 ± 101.8 mg/L (95% CI for mean 343.0-371.7 mg/L), and 182.5 ± 150.0 ng/mL (95% CI for mean 186.9-229.1 ng/mL), respectively. The levels of C3 and C4 increased gradually throughout pregnancy. The levels of C1q, C5a, and sC5b-9 in the first and second trimesters were nearly the same as those in non-pregnant women.

CONCLUSION:

The results of this study show that pregnancy itself may influence the plasma levels of complement system components.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Gravidez Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Gravidez Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article